Get startedLog in
    Picture of CureVac NV logo

    5CV — CureVac NV News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Brief: Curevac Announces Dosing Of First Participant In A Phase 2 Study In Seasonal Influenza

    Picture of CureVac NV logoCureVac NV
    28/05/2024 12:05
    May 28 (Reuters) - CUREVAC NV  5CV.DE :
    * CUREVAC ANNOUNCES DOSING OF FIRST PARTICIPANT IN A PHASE 2
STUDY
IN SEASONAL INFLUENZA; DEVELOPMENT IN COLLABORATION WITH GSK
    * CUREVAC NV SAYS CUREVAC ANNOUNCES DOSING OF FIRST
PARTICIPANT IN
A PHASE 2 STUDY IN SEASONAL INFLUENZA; DEVELOPMENT IN
COLLABORATION WITH GSK

Source text for Eikon:  ID:nEQ96lXP5a 
Further company coverage:  5CV.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on CureVac NV

    See all news